CD4 and HIV infectious disease: Another work examines expanding the offering of ART to HIV-infected individuals with CD4 count ≤ 350 cells/mm3 in South Africa and estimated that it would reduce new HIV infections by more than 250, 000 over five years and nearly 1.5 million over 40 years.